Should You Buy the Rally in Non-US Stocks?

Given the huge amount of U.S. and global central bank easing, it should be no surprise that Non-U.S. stocks are now moving up across the board! Our Chief Equity Strategist and Economist, John Blank, explains now.

1. John, is there more value in these Non-U.S. stocks because U.S. stock market valuations are getting too elevated?

2. Do we run the risk of a market correction this summer because of this?

3. How long do you expect foreign central bank activity to be supportive to non-U.S. stocks?

4. What role does the global pandemic play in this?

5. Are there other geopolitical issues affecting these non-U.S. stocks right now like the U.S./China tensions?

6. There’s also the Q2 earnings season for U.S. S&P 500 companies. If the data comes in bad, as expected, will that depress stock valuations? And if so, will there be renewed value in U.S. stocks?

7. Stocks on your radar this month include Thermo Fisher Scientific (TMO), UBS Group AG (UBS) and Canadian Pacific Railway (CP).

Chief Equity Strategist & Economist, John Blank’s advice, talking Non-U.S. vs U.S. stocks. With John, I’m Terry Ruffolo.

Click to get this free report

UBS Group AG (UBS): Free Stock Analysis Report

Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report

Canadian Pacific Railway Limited (CP): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Technology Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More